Skip to content

Alkem Laboratories shares gain on antifungal drug deal with Biosergen AB

Once the clinical trials are successfully completed in India, Biosergen and Alkem aim to expand its use for similar patient groups in the US and EU via pivotal trials.

Read More

​ Once the clinical trials are successfully completed in India, Biosergen and Alkem aim to expand its use for similar patient groups in the US and EU via pivotal trials. Once the clinical trials are successfully completed in India, Biosergen and Alkem aim to expand its use for similar patient groups in the US and EU via pivotal trials.  Moneycontrol Latest News Read More  

Leave a Reply

en_USEnglish